Efficacy of blonanserin in combination therapy for treatment-resistant depression

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 4, 2009, Pages 593-594

  Kumagai, Ryo ^a   Ichimiya, Yosuke ^a  

^a JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLONANSERIN; CHLORPROMAZINE; FLUVOXAMINE; MILNACIPRAN; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PEROSPIRONE; TRAZODONE; VALPROIC ACID;

ADULT; AGITATION; ANXIETY; CASE REPORT; COMBINATION CHEMOTHERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FATTY LIVER; FEMALE; HUMAN; HYPERPROLACTINEMIA; LETTER; MAJOR DEPRESSION; MONOTHERAPY; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PIPERAZINES; PIPERIDINES; TREATMENT OUTCOME;

EID: 68149109970     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.01966.x     Document Type: Letter

References (4)

1. Ananth J. Treatment-resistant depression. Psychother. Psychosom. 1998 67 : 61 70.
2. Corya SA, Andersen SW, Detke HC et al. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: A 76-week open-label study. J. Clin. Psychiatry 2003 64 : 1349 1356.
3. Zhang W, Perry KW, Wong DT et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 2000 23 : 250 262.
4. Murasaki M. Preclinical and clinical features of blonanserin. Rinsho Seisin Yakuri 2008 11 : 855 868 (in Japanese).